Sinovac Biotech Ltd. (SVA) Reports Unaudited Second Quarter 2013 Financial Results
8/14/2013 6:24:03 AM
Regeneron may be hiring! Check it out! (Isn't it tempting?)
BEIJING, Aug. 13, 2013 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2013.
Second Quarter 2013 Financial Highlights (period-over-period comparisons to second quarter 2012)
•Total sales increased by 86.4% to $17.5 million from $9.4 million.
Help employers find you! Check out all the jobs and post your resume.
comments powered by